Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5

Rising breakthrough infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.4/5 led to the performance of various studies investigating systemic immunity and neutralizing antibodies in sera, but mucosal immunity remains understudied. In this cohort study, the humoral...

Descripción completa

Detalles Bibliográficos
Autores principales: Diem, Gabriel, Jäger, Michael, Dichtl, Stefanie, Bauer, Angelika, Lass-Flörl, Cornelia, Reindl, Markus, Wilflingseder, Doris, Posch, Wilfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269517/
https://www.ncbi.nlm.nih.gov/pubmed/37098903
http://dx.doi.org/10.1128/spectrum.05163-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269517/
https://www.ncbi.nlm.nih.gov/pubmed/37098903
http://dx.doi.org/10.1128/spectrum.05163-22

Ejemplares similares